{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:08:24Z","timestamp":1764079704884,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jss.2021.05.002","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T20:56:51Z","timestamp":1625173011000},"page":"391-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Prognostic Implications of Chemotherapy-Induced Neutropenia in\u00a0Stage III Colorectal Cancer"],"prefix":"10.1016","volume":"267","author":[{"given":"Sungjin","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung IL","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hwang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2021.05.002_bib0001","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1093\/annonc\/mds236","article-title":"ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making","volume":"23","author":"Schmoll","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2021.05.002_bib0002","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12916-015-0547-5","article-title":"A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities","volume":"13","author":"Abraham","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.jss.2021.05.002_bib0003","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/bjc.1997.49","article-title":"Haematological toxicity: a marker of adjuvant chemotherapy efficacy in stage II and III breast cancer","volume":"75","author":"Saarto","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jss.2021.05.002_bib0004","doi-asserted-by":"crossref","first-page":"39018","DOI":"10.18632\/oncotarget.5730","article-title":"Neutropenia predicts better prognosis in patients with metastatic gastric cancer on a combined epirubicin, oxaliplatin and 5-fluorouracil regimen","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jss.2021.05.002_bib0005","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tvjl.2015.04.032","article-title":"Chemotherapy-induced neutropenia is associated with prolonged remission duration and survival time in canine lymphoma","volume":"205","author":"Wang","year":"2015","journal-title":"Vet J"},{"key":"10.1016\/j.jss.2021.05.002_bib0006","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ygyno.2014.03.013","article-title":"Chemotherapy-induced neutropenia as a biomarker of survival in advanced ovarian carcinoma: an exploratory study of the gynecologic oncology group","volume":"133","author":"Tewari","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jss.2021.05.002_bib0007","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.ejca.2009.01.019","article-title":"Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX","volume":"45","author":"Shitara","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2021.05.002_bib0008","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1080\/14737140.2017.1380521","article-title":"Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies","volume":"17","author":"Tan","year":"2017","journal-title":"Exp Rev Anticancer Ther"},{"key":"10.1016\/j.jss.2021.05.002_bib0009","unstructured":"National Comprehensive Cancer Network. Hematopoietic growth factor (Version 2. 2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/growthfactors.pdf. Accessed Jan 27, 2020"},{"key":"10.1016\/j.jss.2021.05.002_bib0010","first-page":"440","article-title":"Myelotoxicity and dose intensity of chemotherapy: reporting practices from randomized","volume":"1","author":"Dale","year":"2003","journal-title":"Clin Trials"},{"key":"10.1016\/j.jss.2021.05.002_bib0011","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: american society of clinical oncology clinical practice guideline update","volume":"33","author":"Smith","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2021.05.002_bib0012","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s12029-014-9639-2","article-title":"Neutropenia and relative dose intensity on adjuvant FOLFOX chemotherapy are not associated with survival for resected colon cancer","volume":"45","author":"Smoragiewicz","year":"2014","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.jss.2021.05.002_bib0013","first-page":"394","article-title":"The association between neutropenia and prognosis in stage III colorectal cancer patients receiving adjuvant chemotherapy","volume":"23","author":"Sunaga","year":"2014","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.jss.2021.05.002_bib0014","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1200\/JCO.2005.06.075","article-title":"Associations between drug metabolism genotype, chemotherapy pharmacokinetics, and overall survival in patients with breast cancer","volume":"23","author":"Petros","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2021.05.002_bib0015","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1200\/JCO.1996.14.9.2590","article-title":"Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative","volume":"14","author":"Gurney","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2021.05.002_bib0016","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2015.11.008","article-title":"Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: ready for prime time","volume":"54","author":"Lunenburg","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jss.2021.05.002_bib0017","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1093\/annonc\/mdx411","article-title":"DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update","volume":"28","author":"Henricks","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jss.2021.05.002_bib0018","first-page":"3612","article-title":"Gamelin: individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer","volume":"31","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jss.2021.05.002_bib0019","doi-asserted-by":"crossref","first-page":"11527","DOI":"10.1038\/s41598-019-47627-1","article-title":"Sex-related differences in impact on safety of pharmacogenetic profile for colon cancer patients treated with FOLFOX-4 or XELOX adjuvant chemotherapy","volume":"9","author":"Ruzzo","year":"2019","journal-title":"Sci Rep"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480421003000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480421003000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:57:27Z","timestamp":1758380247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480421003000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":19,"alternative-id":["S0022480421003000"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2021.05.002","relation":{},"ISSN":["0022-4804"],"issn-type":[{"type":"print","value":"0022-4804"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Implications of Chemotherapy-Induced Neutropenia in\u00a0Stage III Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2021.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}